HomeCompareCYCL vs KMB

CYCL vs KMB: Dividend Comparison 2026

CYCL yields 5449.59% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CYCL wins by $143733464720535.22M in total portfolio value
10 years
CYCL
CYCL
● Live price
5449.59%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$143733464720535.28M
Annual income
$138,725,846,299,534,620,000.00
Full CYCL calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — CYCL vs KMB

📍 CYCL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCYCLKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CYCL + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CYCL pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYCL
Annual income on $10K today (after 15% tax)
$463,215.26/yr
After 10yr DRIP, annual income (after tax)
$117,916,969,354,604,430,000.00/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, CYCL beats the other by $117,916,969,354,604,430,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYCL + KMB for your $10,000?

CYCL: 50%KMB: 50%
100% KMB50/50100% CYCL
Portfolio after 10yr
$71866732360267.66M
Annual income
$69,362,923,149,767,310,000.00/yr
Blended yield
96.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

CYCL
No analyst data
Altman Z
-11.1
Piotroski
2/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYCL buys
0
KMB buys
0
No recent congressional trades found for CYCL or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCYCLKMB
Forward yield5449.59%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17%
Portfolio after 10y$143733464720535.28M$45.9K
Annual income after 10y$138,725,846,299,534,620,000.00$5,222.34
Total dividends collected$143395578499210.66M$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: CYCL vs KMB ($10,000, DRIP)

YearCYCL PortfolioCYCL Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$555,659$544,959.13$11,314$614.45+$544.3KCYCL
2$28,894,697$28,300,141.49$12,867$760.19+$28.88MCYCL
3$1,406,271,396$1,375,354,070.21$14,713$945.27+$1406.26MCYCL
4$64,062,549,885$62,557,839,491.91$16,924$1,181.90+$64062.53MCYCL
5$2,731,926,360,480$2,663,379,432,103.12$19,596$1,486.64+$2731926.34MCYCL
6$109,071,702,807,331$106,148,541,601,617.23$22,850$1,882.16+$109071702.78MCYCL
7$4,077,419,583,262,203$3,960,712,861,258,358.50$26,849$2,399.80+$4077419583.24MCYCL
8$142,739,514,323,666,200$138,376,675,369,575,650.00$31,812$3,083.36+$142739514323.63MCYCL
9$4,680,017,215,888,471,000$4,527,285,935,562,148,400.00$38,033$3,994.72+$4680017215888.43MCYCL
10$143,733,464,720,535,270,000$138,725,846,299,534,620,000.00$45,918$5,222.34+$143733464720535.22MCYCL

CYCL vs KMB: Complete Analysis 2026

CYCLStock

Cycclone Inc., together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the beneficial microorganism colonies in soil; inhibit the reproduction of harmful fungi and putrefactive bacteria; and to improve nutrient absorption and reduce crop and livestock diseases. It also provides AM/HM bacteria based additives for livestock feed, which softens the livestock feed and restrain the growth and reproduction of pathogenic bacteria, as well as supplies beneficial nutriments, including organic acid, vitamins, enzyme, antibiotics, mycelium protein, and other growth-enhancing substances that balance the nutrients in the feed. In addition, the company offers FGW bacterial based preservatives that preserve animal specimens for scientific research; and preserve the freshness for agricultural produce. Further, it provides bacteria based fertilizer for application on plants, such as vegetable and fruit leaves. Additionally, the company engages in residential and commercial real estate investment. The company was formerly known as China Dasheng Biotechnology Co. and changed its name to Cycclone Inc. in May 2025. Cycclone Inc. was founded in 2004 and is based in Lanzhou, China.

Full CYCL Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this CYCL vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYCL vs SCHDCYCL vs JEPICYCL vs OCYCL vs KOCYCL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.